Results 151 to 160 of about 1,970,613 (261)

Scientific Research Trend on Guided Tissue Regeneration: A Bibliometric Analysis. [PDF]

Eur J Dent
Alhumaidan AA, Alam BF, Alsuwaiyan A, Aljoghaiman EA, Helmi M, Ali S.   +5 more
europepmc   +1 more source

Worldwide productivity and research trend of publications concerning electroactive materials and spinal cord injury: A bibliometric study. [PDF]

Front Bioeng Biotechnol, 2023
Liu S, Song L, Dai W, Liu M, Zhang H, Zhang X, Li H, Liu X, Lv Y, Hu Y.   +9 more
europepmc   +1 more source

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

Molecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder, Klaas de Lint, Hồ Mỹ Phúc Võ, Mariana M. Góis, Rosalie A. Kampen, Marta San Martin Alonso, Ilse Nootenboom, Veronica Garzero, Tiemen J. Wendel, Rob M. F. Wolthuis, Sylvie M. Noordermeer   +10 more
wiley   +1 more source

The Significance of Probiotics in Aquaculture: A Review of Research Trend and Latest Scientific Findings. [PDF]

Antibiotics (Basel)
Mohammed EAH, Ahmed AEM, Kovács B, Pál K.   +3 more
europepmc   +1 more source

Integrating the digital twin concept into the evaluation of reconfigurable manufacturing systems (RMS): literature review and research trend. [PDF]

Int J Adv Manuf Technol, 2023
Touckia JK.
europepmc   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

Molecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi, Stavros Makrodimitris, Sandra van Wilpe, Iris te Paske, Vanja de Weerd, Corine M. Beaufort, Hans M. Westgeest, Jens Voortman, Maureen J. B. Aarts, Maud Rijnders, Astrid A. M. van der Veldt, Ronald de Wit, Niven Mehra, Saskia M. Wilting, Debbie G. J. Robbrecht   +14 more
wiley   +1 more source

Global research trend of Herpes simplex keratitis: a bibliometric analysis and visualization from 1941 to 2024. [PDF]

Front Med (Lausanne)
Song K, Li S, Liu J, Kang Z.
europepmc   +1 more source

Issues in sustainable supply chain's futuristic technologies: a bibliometric and research trend analysis. [PDF]

Environ Sci Pollut Res Int, 2022
Wangsa ID, Vanany I, Siswanto N.
europepmc   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

Molecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka, Wioleta Cieślik, Wojciech Płaziński, Katarzyna Stępnik, Anna Boguszewska‐Czubara, Elżbieta Kot, Robert Musioł, Mateusz Jasica, Anna Mrozek‐Wilczkiewicz, Katarzyna Malarz   +9 more
wiley   +1 more source

From Research Trend to Performance Prediction: Metaheuristic-Driven Machine Learning Optimization for Cement Pastes Containing Bio-Based Phase Change Materials. [PDF]

Polymers (Basel)
Li L, Sun W, Gómez-Zamorano LY, Liu Z, Zhang W, Ma H.   +5 more
europepmc   +1 more source